Conversion to sirolimus of patients with chronic allograft nephropathy - A retrospective analysis of outcome and influencing factors

Oliver Witzke, Ondrej Viklicky, Tobias R. Türk, Jens Lutz, Benjamin Wilde, Isabel Willenberg, Stefan Vitko, Uwe Heemann

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Purpose: The purpose of this study was to analyse the outcome and its influencing factors in patients whose therapy was converted from calcineurin inhibitors (CNI) to sirolimus (SRL) due to chronic allograft nephropathy (CAN). Materials and methods: Therapies of 78 patients (44 men) with CAN from three European transplant centres were converted from CNI therapy to SRL and followed 24 months. Slopes for creatinine clearance before and after conversion were calculated. Influencing factors were analysed by a multivariance analysis. Results: The slope of the creatinine clearance improved significantly (-0.90 vs. -0.34 ml min-1 month-1; p∈<∈0.01). In patients whose therapy was converted from cyclosporine A (CyA) to SRL, the slope improved significantly, whereas conversion from Tacrolimus (Tac) to SRL did not affect the slope. The benefit was more pronounced in (1) patients with low or moderate baseline creatinine clearance, (2) patients receiving SRL after conversion without additional mycophenolate mofetil and (3) patients with low or moderate proteinuria. Conclusion: Conversion from CyA to SRL but not from Tac to CRL is associated with a reduced loss of renal allograft function in patients with CAN.

Original languageEnglish
Pages (from-to)1073-1078
Number of pages6
JournalLangenbeck's Archives of Surgery
Volume394
Issue number6
DOIs
StatePublished - Nov 2009

Keywords

  • Interstitial fibrosis
  • Renal transplantation
  • Tubular atrophy

Fingerprint

Dive into the research topics of 'Conversion to sirolimus of patients with chronic allograft nephropathy - A retrospective analysis of outcome and influencing factors'. Together they form a unique fingerprint.

Cite this